BACKGROUND: Systemic inflammation and endothelial activation are implicated in the development of hypertension. However, epidemiologic studies have yet to compare multiple corresponding biomarkers in relation to risk of hypertension, particularly in multiethnic populations.
Hypertension is the most common chronic disease in the US (1 ), affecting more than 74.5 million adults in 2003-2006 (2 ) . Although research into the etiology of hypertension has yielded an important array of lifestyle, dietary, and psychosocial factors, relevant biochemical markers for risk of hypertension are comparatively less studied.
Both chronic inflammation and endothelial activation are pathophysiologic processes potentially implicated in the development of hypertension (3 ) . Laboratory studies have shown that inflammatory markers attenuate the synthesis of nitric oxide (NO) 9 in endothelial cells (4, 5 ) and stimulate progressive endothelial dysfunction (6, 7 ) . A diminished bioavailability of NO and impaired vascular tone due to the defective endothelium will result in the elevation of blood pressure (BP) (8, 9 ) . A number of cross-sectional studies have demonstrated high circulating levels of inflammatory markers among human subjects with increased BP or hypertension (10 -14 ) . Meanwhile, only a few prospective studies have examined baseline plasma inflammatory markers, typically including C-reactive protein (CRP), with the subsequent risk of hypertension among initially normotensive individuals (15) (16) (17) (18) .
Similarly, studies on plasma endothelial markers and hypertension have been limited to cross-sectional studies (19 -21 ) and retrospective case-control studies (22) (23) (24) , in which no causal link can be established.
Hypertension is particularly prevalent and poorly controlled and causes more severe complications in black vs white individuals (25 ) . Differences in inflammatory markers (26, 27 ) and endothelial markers (28 ) exist between blacks and whites, whereas few studies have examined whether the associations of these biomarkers with risk of hypertension differ by race/ethnicity. We therefore investigated the prospective association of several circulating markers of inflammation and endothelial activation with incident hypertension in a nested case-control study within a multiethnic cohort of postmenopausal women.
Materials and Methods

STUDY PARTICIPANTS
The Women's Health Initiative Observational Study (WHI-OS) is a prospective cohort study that examined risk factors for chronic disease among ethnically diverse postmenopausal women. Details of the study rationale and design have been reported (29 ) . The study has been reviewed and approved by human subjects review committees at each participating institution, and signed informed consent was obtained from all participants.
Of the 93 676 postmenopausal women enrolled into the WHI-OS, the baseline population for our study consisted of women who were free of hypertension, cardiovascular disease, peripheral vascular disease, and cancer and who had provided sufficient baseline blood samples. To minimize the misclassification of borderline hypertension, we defined women free of hypertension as having a measured systolic BP (SBP) Ͻ135 mmHg and diastolic BP (DBP) Ͻ85 mmHg, no physician diagnosis of hypertension, and no past or current antihypertensive medication use. BP was measured at baseline visit using standard protocols, with study participants sitting for 5 min before measurement. The mean of 2 BP readings, obtained 30 s apart, was used for analysis. To minimize the impact of preexisting atherosclerosis, our baseline population was also limited to women aged Ͻ70 years. From a baseline population of 36 043 women, incident hypertension was identified during a median follow-up of 5.9 years, defined as the initiation of medication specifically for increased BP and/or measured BP at the year-3 follow-up visit of either SBP Ն140 mmHg or DBP Ն90 mmHg. Antihypertensive medication use was reported on annual follow-up questionnaires and confirmed by the year-3 and/or year-6 follow-up medication inventories review.
For this nested case-control study, we randomly selected 400 white women and 400 black women who developed incident hypertension among 5251 eligible cases in the WHI-OS cohort. Based on risk-set sampling, for each case we randomly selected a control from women who maintained SBP Ͻ135 mmHg and DBP Ͻ85 mmHg and remained free of antihypertensive medications and major morbidity until the case was identified (Ϯ3 months). Each control was also matched to respective case by age (Ϯ2 years), race/ethnicity (white/Caucasian or black/African American), clinical center (geographic location), and time of enrollment (Ϯ2 years).
PLASMA BIOMARKER ASSAYS
Blood samples were obtained from each WHI participant and collected into anticoagulated (citrate and EDTA) tubes. Samples were spun for 10 min at 13 000g in a refrigerated centrifuge within 30 -45 min of blood collection. Following standardized procedures, all plasma samples were then aliquoted within 15 min after centrifugation and frozen at Ϫ70°C for short-term local storage. Samples were batch-shipped on dry ice to a central facility (McKesson BioServices) for long-term storage until analysis.
For our nested case-control study, we measured 4 inflammatory markers, including high-sensitivity CRP (hsCRP), interleukin (IL)-6, IL-1␤, and tumor necrosis factor (TNF) receptor 2 (TNF-r2), which shows a strong correlation with TNF-␣ mRNA expression in human adipose tissue (30 ) , plus a marker of endothelial activation, soluble intercellular adhesion molecule 1 (sICAM-1) in plasma. We measured hsCRP by an ultrasensitive immunotechnique (Dade Behring), IL-6 by a quantitative sandwich enzyme immunoassay (Quantikine HS Immunoassay Kit), IL-1␤ by commercially available ELISA (Pelikine Compact human IL-1␤ ELISA kits, CLB), TNF-r2 by an ELISA kit with immobilized monoclonal antibody to human TNF-r2 (Genzyme), and sICAM-1 by ELISA (R&D Systems). All investigators and laboratory personnel were blinded to the case-control status of the sample donors. All blood samples were handled identically throughout the processes of blood collection, storage, retrieval, and assays. Assay results clearly out of range were considered outliers and excluded-1 study participant each was excluded for hsCRP, TNF-r2, and sICAM-1. The intraassay CVs were 3.3% for hsCRP, 9.5% for IL-6, 20.5% for IL-1␤, 9.9% for TNF-r2, and 5.7% for sICAM-1.
ASSESSMENT OF OTHER BASELINE COVARIATES
At baseline in the WHI-OS, participants self-reported extensive information on demographic characteristics, education and income, lifestyle factors, diet, medical history, and medication use. Physical activity was as-sessed on the basis of the frequency, intensity, and duration of walking and recreational activities and presented as metabolic equivalents ϫ activity duration (h) (MET-h: 1 MET ϭ 1 kcal/kg body weight/h) per week. Hypercholesterolemia was defined by self-reported cholesterol-lowering medication use. Diabetes was defined by self-reported physician diagnosis. Postmenopausal hormone therapy use was also ascertained from self-report. During the baseline clinic visit, body weight was measured using a calibrated balance beam scale, and height was measured using a calibrated, wall-mounted stadiometer, from which body mass index (BMI) was calculated (kg/m 2 ). Waist circumference was measured at the end of normal expiration over nonbinding undergarments in a horizontal plane at the natural waist.
STATISTICAL ANALYSIS
We conducted analyses for white and black women separately using SAS version 9.1 (SAS Institute). We first checked each biomarker for outliers and used logarithmic transformation to normalize the skewed distribution for hsCRP, IL-6, and IL-1␤. We compared major hypertension risk factors and baseline circulating biomarker concentrations between hypertension cases and controls. We also divided each biomarker into quartiles on the basis of its distribution among controls and compared hypertension risk factors. We then calculated relative risk (RR) and 95% CI of incident hypertension for each quartile of biomarker using conditional logistic regression, with the lowest quartile as the reference. Crude models adjusted for matching factors including age, clinical center, and time of enrollment. Multivariable models additionally adjusted for known lifestyle risk factors for hypertension, including cigarette smoking (current, former, never), alcohol intake (never, former, Ͻ1 drink/month, Ͻ1 drink/week, 1 to Ͻ7 drinks/week, Ն7 drinks/week), recreational physical activity (total MET-h/week), and hormone replacement therapy (never, former, current). We finally adjusted for measures of adiposity (BMI and waist circumference). We also conducted stratified analyses by BMI (Ͻ25, 25 to Ͻ30, Ն30 kg/ m 2 ) and waist circumference (Ͻ77, 77 to Ͻ88, Ն88 cm).
Several sensitivity analyses were also performed. First, we excluded women with baseline prehypertension (SBP/DBP between 120/80 and 135/85 mmHg); second, we excluded women with baseline diabetes; third, we additionally adjusted for baseline SBP; and fourth, we adjusted for BMI and waist circumference with their quadratic terms to control for possible curvilinear relations. The results were generally similar to main analyses and are not presented.
Results
Baseline characteristics of hypertension cases compared with matched controls are shown in Table 1 . On average, black women in this study were younger, heavier, less physically active, and more likely to be diabetic than white women regardless of case/control status. Both white and black women with incident hypertension had higher BMI and waist circumference and engaged in less physical activity compared with respective controls. Black women with incident hypertension were also more likely to have diabetes than controls. Cigarette smoking, alcohol consumption, and history of hypercholesterolemia were generally similar in cases and controls. Comparing baseline biomarkers, mean concentrations of hsCRP and IL-6 were higher, whereas mean concentrations of TNF-r2 and sICAM-1 were lower, in black cases and controls than in white cases and controls. For both white and black women, baseline hsCRP and IL-6 were significantly higher in cases than controls. Baseline TNF-r2 and sICAM-1 were significantly higher in black cases vs controls, but similar among white case-control pairs. Baseline IL-1␤ did not differ by case and control for either whites or blacks.
The associations between baseline concentrations of biomarkers and risk of hypertension in white and black women are shown in Table 2 . In white women, using crude models that adjusted only for matching factors, plasma hsCRP and IL-6 were each positively associated with the risk of developing hypertension. In black women, the crude models showed positive associations of plasma hsCRP, IL-6, and TNF-r2 with the risk of hypertension. Additional multivariable adjustment for other hypertension risk factors did not materially change these associations, with RR and 95% CI of hypertension in the highest vs lowest quartile of 2.02 (1.29 -3.14) for hsCRP and 1.64 (1.06 -2.55) for IL-6 in white women; 1.64 (1.07-2.52) for hsCRP, 1.99 (1.27-3.12) for IL-6, and 1.67 (1.08 -2.57) for TNF-r2 in black women.
Because all inflammatory markers except IL-1␤ were significantly and positively correlated with BMI and waist circumference in controls (Spearman r ranging from 0.15 to 0.41 in whites and 0.17 to 0.54 in blacks), whereas sICAM-1 was positively correlated with measures of adiposity in white, but not black, women, we particularly examined how adjustment for measures of obesity impacted the association between each biomarker and risk of hypertension (Fig. 1) . Because BMI and waist circumference were highly correlated, subsequent regression models adjusted for these 2 measures separately. In both white and black women, adjustment for BMI substantially attenuated the positive associations between inflammatory markers and incident hypertension. The resulting multivariable RRs and 95% CIs of hypertension in the highest quartile were 1.52 (0.94 -2.48) and 1.23 (0.76 -1.97) for hsCRP and IL-6 in white women and 1.30 (0.81-2.07), 1.58 (0.96 -2.59), and 1.49 (0.94 -2.36) for hsCRP, IL-6, and TNF-r2 in black women. Adjustment for waist circumference attenuated the RRs similarly.
We further evaluated the associations of multiple biomarkers with the risk of hypertension across categories of baseline BMI and waist circumference (Table 3) . In white women, there was no association between each biomarker and risk of hypertension in any category of BMI or waist circumference. In black women, plasma hsCRP was significantly and positively associated with risk of hypertension for those with BMI Ͻ25 kg/m 2 (RR 2.91, 95% CI 0.995-8.52) or waist circumference Ͻ77 cm (RR 4.43, 95% CI 1.24 -15.9), with no similar associations found for heavier women. Nevertheless, the tests for interactions did not reach statistical significance (P interaction Ͼ 0.05).
Discussion
In this prospective nested case-control study, before adjustment for measures of adiposity, we found positive associations between plasma concentrations of hsCRP and IL-6 and risk of hypertension in both white and black women, and a positive association between concentrations of TNF-r2 and risk of hypertension in black, but not white, women. These associations became nonsignificant after adjustment for BMI and waist circumference. Neither IL-1␤ nor sICAM-1 was associated with the risk of hypertension in any model of white and black women. Accumulating evidence suggests that systemic inflammation and endothelial activation underlie the development of hypertension (3 ) . Experimental studies show that CRP, the most extensively studied inflammatory marker, may stimulate endothelial activation by decreasing the expression and activity of NO synthase (4, 5 ) , facilitating release of endothelin 1 (6 ), and reducing endothelial progenitor cell survival and differentiation (31 ) . In endothelium activation and subsequent dysfunction, endothelium-dependent vasorelaxation is impaired (9 ) and vascular tone compromised (32 ) , ultimately leading to increases in BP. On the surface of activated endothelial cells, the expression of cell adhesion molecules such as ICAM-1 and vascular adhesion molecule 1 (VCAM-1) is markedly increased, which is accompanied by release of the soluble (34 ) . Inflammatory cytokines may also promote the development of hypertension through other endothelium-independent mechanisms (35) (36) (37) . Previous epidemiologic studies have linked higher plasma concentrations of inflammatory markersincluding CRP (10, 12 ) , 11 ) , IL-1␤ (13 ), and TNF-␣ (14 )-to increased SBP and DBP or hypertensive status. With current evidence predominantly from cross-sectional or retrospective studies, it has been unclear whether inflammation is a cause or a consequence of hypertension. The prospective association between CRP and incident hypertension was examined in a few studies. In some (15, 17 ) but not all (18 ) studies, a positive association remained significant after controlling for BMI. In a nested case-control study examining both hsCRP and IL-6, the positive associations of both inflammatory markers with hypertension risk were greatly attenuated after adjustment for BMI (16 ) .
Our study extends earlier investigations to other inflammatory markers, including IL-1␤ and TNF-r2, whose associations with incident hypertension had not been examined in prospective studies, to our knowledge. Our study also extends previous cross-sectional and case-control studies of endothelial markers with BP or hypertension (19 -24 ) to prospective study. We found that black women who developed hypertension had higher plasma concentrations of sICAM-1 at baseline, but this association was attenuated to nonsignificance after multivariable adjustment. Because each adhesion molecule may mediate alterations to the endothelium through different mechanisms (19 ) , our findings for a single adhesion molecule cannot exclude the possibility that other markers of endothelial function might play important roles in the development of hypertension.
Our study underscores the complex interrelationships between inflammation, adiposity, and pathogenesis of hypertension. Obesity is a well-known predictor of hypertension and may confound the association between inflammation and hypertension. Meanwhile, inflammation and obesity share common pathways leading to hypertension, such as upregulation of the renin-angiotensin system (35, 38 ) and disturbance of insulin actions (39 ) . Furthermore, adipose tissue has been characterized as a dynamic endocrine organ that produces proinflammatory cytokines (40 ) , which makes it more difficult to distinguish the independent effect of inflammation and obesity on hypertension. In our stratified analyses, there was a significant association between high plasma concentrations of hsCRP and increased risk of hypertension among black women with either BMI Ͻ25 kg/m 2 or waist circumference Ͻ77 cm, suggesting that the association between inflammation and hypertension could be stronger among leaner individuals. Our prospective nested case-control study within the multiethnic WHI-OS simultaneously examined multiple plasma markers of inflammation and endothelial activation in association with risk of hypertension. There are several limitations of this study that deserve attention. First, only a single baseline measurement of each biomarker was available, whereby random misclassification tends to bias the associations toward the null. In addition, some biomarkers, such as IL-1␤, had high CVs that would partly explain the null findings with hypertension. Second, despite comprehensive adjustment for known hypertension risk factors, residual confounding may persist. Third, other potentially important biomarkers of endothelium activation (e.g., VCAM-1 and selectins) and alternative measures of endothelial function were not assessed in our study. Finally, the WHI-OS cohort consisted of postmenopausal women only. Additional studies are necessary to further examine the associations between inflammatory and endothelial markers with risk of hypertension in men and in other ethnically diverse populations.
In conclusion, in this multiethnic study investigating multiple inflammatory and endothelial markers for the risk of hypertension, we found a positive association for plasma hsCRP and IL-6 with hypertension risk in both white and black women, along with a positive association for plasma TNF-r2 with hypertension risk in black, but not white, women. However, these associations were weakened upon adjustment for BMI and waist circumference. Additional studies are needed to clarify the interrelationships between inflammation and adiposity in the development of hypertension. 
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